tirzepatide harrisburg nc Flex-Dose 3 mL Injectable 10 mg/mL Compounded Tirzepatide Is Changing Weight

During a telehealth appointment, a licensed healthcare provider reviews: For many patients, both the initial evaluation and follow-up visits can be completed entirely through telehealth, depending on clinical appropriateness

Obesity medicine specialist or endocrinologist

Providers should monitor weight trajectory , GI tolerability (nausea, vomiting, constipation) , signs of pancreatitis (persistent severe abdominal pain vomiting), gallbladder disease (RUQ pain, fever, jaundice), hydration/renal function when clinically indicated (risk of AKI with severe GI effects), blood pressure , and glucose metrics (especially if combined with insulin or sulfonylureas due to hypoglycemia risk)

There is not enough data from human studies, and there is a risk of exposing infants to the drug